Kim R - Search Results

1

The Role of Angiogenesis in Hepatocellular Carcinoma.

Morse MA, Sun W, Kim R, He AR, Abada PB, Mynderse M, Finn RS. Morse MA, et al. Among authors: kim r. Clin Cancer Res. 2019 Feb 1;25(3):912-920. doi: 10.1158/1078-0432.CCR-18-1254. Epub 2018 Oct 1. Clin Cancer Res. 2019. PMID: 30274981 Review.

2

Is there a role for adjuvant treatment after hepatic resection for hepatocellular carcinoma?

Tan A, Aucejo F, Kim R. Tan A, et al. Among authors: kim r. Oncology. 2010;78(3-4):161-71. doi: 10.1159/000315577. Epub 2010 Jun 8. Oncology. 2010. PMID: 20530972 Review.

3

Radiologic complete response with sirolimus and sorafenib in a hepatocellular carcinoma patient who relapsed after orthotopic liver transplantation.

Kim R, Aucejo F. Kim R, et al. J Gastrointest Cancer. 2011 Mar;42(1):50-3. doi: 10.1007/s12029-010-9196-2. J Gastrointest Cancer. 2011. PMID: 20714941

4

Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation.

Kim R, El-Gazzaz G, Tan A, Elson P, Byrne M, Chang YD, Aucejo F. Kim R, et al. Oncology. 2010;79(1-2):62-6. doi: 10.1159/000319548. Epub 2010 Nov 11. Oncology. 2010. PMID: 21071991

5

What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge.

Kim R, Byrne MT, Tan A, Aucejo F. Kim R, et al. Oncology (Williston Park). 2011 Mar;25(3):283-91, 295. Oncology (Williston Park). 2011. PMID: 21548473 Free article. Review.

6

Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy.

Estfan B, Byrne M, Kim R. Estfan B, et al. Among authors: kim r. Am J Clin Oncol. 2013 Aug;36(4):319-24. doi: 10.1097/COC.0b013e3182468039. Am J Clin Oncol. 2013. PMID: 22547010

7

Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.

Zhang W, Kim R, Quintini C, Hashimoto K, Fujiki M, Diago T, Eghtesad B, Miller C, Fung J, Tan A, Menon KV, Aucejo F. Zhang W, et al. Among authors: kim r. Liver Transpl. 2015 Jan;21(1):101-11. doi: 10.1002/lt.24013. Liver Transpl. 2015. PMID: 25283528 Free article.

8

Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?

Mahipal A, Choi M, Kim R. Mahipal A, et al. Among authors: kim r. J Natl Compr Canc Netw. 2015 Oct;13(10):1281-91; quiz 1292. doi: 10.6004/jnccn.2015.0154. J Natl Compr Canc Netw. 2015. PMID: 26483065 Review.

9

Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy.

Kim DW, Talati C, Kim R. Kim DW, et al. Among authors: kim r. J Gastrointest Oncol. 2017 Apr;8(2):256-265. doi: 10.21037/jgo.2016.09.07. J Gastrointest Oncol. 2017. PMID: 28480065 Free PMC article. Review.

10

Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma.

Eatrides J, Wang E, Kothari N, Kim R. Eatrides J, et al. Among authors: kim r. Cancer Control. 2017 Jul-Sep;24(3):1073274817729243. doi: 10.1177/1073274817729243. Cancer Control. 2017. PMID: 28975834 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,836 results

Search Page

Filters